2003 - 2013年德国侵袭性化脓性链球菌分离株的抗菌药敏性
Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.
作者信息
Imöhl Matthias, van der Linden Mark
机构信息
Institute of Medical Microbiology and National Reference Center for Streptococci, University Hospital RWTH Aachen, Aachen, Germany.
出版信息
PLoS One. 2015 Sep 4;10(9):e0137313. doi: 10.1371/journal.pone.0137313. eCollection 2015.
Abstract
A nationwide laboratory-based surveillance study of invasive S. pyogenes infections was conducted in Germany. Invasive isolates (n = 1,281) were obtained between 2003 and 2013. All isolates were susceptible to penicillin, cefotaxime and vancomycin. Tetracycline showed the highest rate of resistant or intermediate resistant isolates with 9.8%, followed by macrolides (4.0%), trimethoprim/sulfamethoxazole (SXT) (1.9%), levofloxacin (1.3%), chloramphenicol (0.9%) and clindamycin (0.7%). The most prominent trends were the appearance of levofloxacin non-susceptible isolates since 2011, and an increase of SXT non-susceptibility since 2012.
摘要
在德国开展了一项基于实验室的全国性侵袭性酿脓链球菌感染监测研究。在2003年至2013年期间获取了侵袭性分离株（n = 1281）。所有分离株对青霉素、头孢噻肟和万古霉素敏感。四环素耐药或中介耐药分离株的比例最高，为9.8%，其次是大环内酯类（4.0%）、甲氧苄啶/磺胺甲恶唑（SXT）（1.9%）、左氧氟沙星（1.3%）、氯霉素（0.9%）和克林霉素（0.7%）。最显著的趋势是自2011年以来出现了左氧氟沙星不敏感分离株，以及自2012年以来SXT不敏感性增加。
相似文献
1
Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.2003 - 2013年德国侵袭性化脓性链球菌分离株的抗菌药敏性
PLoS One. 2015 Sep 4;10(9):e0137313. doi: 10.1371/journal.pone.0137313. eCollection 2015.
2
Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study.以色列北部A组链球菌对抗菌药物的敏感性：一项监测研究。
Microb Drug Resist. 2015 Oct;21(5):551-5. doi: 10.1089/mdr.2015.0040. Epub 2015 Jun 2.
3
Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel.从以色列南部侵袭性疾病患者中分离出的化脓性链球菌的血清分型及其对大环内酯类和其他抗菌药物的敏感性
Eur J Clin Microbiol Infect Dis. 1997 Jan;16(1):20-3. doi: 10.1007/BF01575115.
4
Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007.2003年至2007年德国侵袭性化脓性链球菌疾病的流行病学
FEMS Immunol Med Microbiol. 2010 Apr;58(3):389-96. doi: 10.1111/j.1574-695X.2010.00652.x. Epub 2010 Jan 19.
5
The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.来自费城地区的化脓性链球菌分离株的抗菌药敏性。
Adv Exp Med Biol. 1995;390:119-21. doi: 10.1007/978-1-4757-9203-4_10.
6
Throat Carriage Rate and Antimicrobial Resistance of In Rural Children in Argentina.阿根廷农村儿童的咽喉携带率及抗菌药物耐药性
J Prev Med Public Health. 2017 Mar;50(2):127-132. doi: 10.3961/jpmph.15.073. Epub 2017 Jan 4.
7
[Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].[西班牙科尔多瓦咽部分泌物中化脓性链球菌分离株的易感性]
Rev Esp Quimioter. 2003 Mar;16(1):58-60.
8
[Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].[西班牙瓜达拉哈拉地区化脓性链球菌对大环内酯类和喹诺酮类药物的敏感性]
Rev Esp Quimioter. 2003 Mar;16(1):61-4.
9
In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.β-内酰胺类和非β-内酰胺类药物对来自澳大利亚悉尼的肺炎链球菌分离株的体外抗菌活性。
Pathology. 2006 Aug;38(4):343-8. doi: 10.1080/00313020600820732.
10
[Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].[法国儿科患者中耐大环内酯类化脓性链球菌菌株的出现]
Pathol Biol (Paris). 2004 Oct;52(8):489-92. doi: 10.1016/j.patbio.2004.07.032.
引用本文的文献
1
General Practitioner's Practice in Romanian Children with Streptococcal Pharyngitis.罗马尼亚儿童链球菌性咽炎的全科医生诊疗实践
Medicina (Kaunas). 2025 Aug 2;61(8):1408. doi: 10.3390/medicina61081408.
2
Dihydrothiazolo ring-fused 2-pyridone antimicrobial compounds treat skin and soft tissue infection.二氢噻唑并并吡啶酮类抗菌化合物治疗皮肤和软组织感染。
Sci Adv. 2024 Aug 2;10(31):eadn7979. doi: 10.1126/sciadv.adn7979.
3
Invasive Group A Streptococcal Infections in Europe After the COVID-19 Pandemic.新冠疫情后欧洲的侵袭性A组链球菌感染
Dtsch Arztebl Int. 2024 Oct 4;121(20):673-680. doi: 10.3238/arztebl.m2024.0127.
4
Burden of Antibiotic Resistance at Wolaita Sodo University Comprehensive Specialized Hospital.沃莱塔索多大学综合专科医院的抗生素耐药负担
Biomed Res Int. 2022 Jun 2;2022:7272024. doi: 10.1155/2022/7272024. eCollection 2022.
5
Comment on: "Prevalence, Antibiotic Susceptibility Profile and Associated Factors of Group A Streptococcal Pharyngitis Among Pediatric Patients with Acute Pharyngitis in Gondar, Northwest Ethiopia" [Letter].关于《埃塞俄比亚西北部贡德尔急性咽炎儿科患者中 A 组链球菌性咽炎的患病率、抗生素敏感性概况及相关因素》[信函]的评论
Infect Drug Resist. 2023 May 8;16:2783-2785. doi: 10.2147/IDR.S418143. eCollection 2023.
6
Time to negative throat culture following initiation of antibiotics for pharyngeal group A : a systematic review and meta-analysis up to October 2021 to inform public health control measures.开始使用抗生素治疗咽峡炎 A 组群后进行咽拭子培养的时间：截至 2021 年 10 月的系统评价和荟萃分析，为公共卫生控制措施提供信息。
Euro Surveill. 2023 Apr;28(15). doi: 10.2807/1560-7917.ES.2023.28.15.2200573.
7
An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics.链球菌中大环内酯类耐药性概述：流行情况、移动元件及动态变化
Microorganisms. 2022 Nov 23;10(12):2316. doi: 10.3390/microorganisms10122316.
8
Host-dependent resistance of Group A Streptococcus to sulfamethoxazole mediated by a horizontally-acquired reduced folate transporter.宿主依赖性 A 组链球菌对磺胺甲噁唑的耐药性由水平获得的还原叶酸转运蛋白介导。
Nat Commun. 2022 Nov 30;13(1):6557. doi: 10.1038/s41467-022-34243-3.
9
Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections.克林霉素而非静脉注射免疫球蛋白可降低菌血症性 A 组链球菌感染危重症患者的死亡率。
Rev Esp Quimioter. 2022 Oct;35(5):475-481. doi: 10.37201/req/030.2022. Epub 2022 Jul 7.
10
Isolation of Group A Streptococci with Reduced β-Lactam Susceptibility Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan.日本分离出具有青霉素结合蛋白氨基酸取代的β-内酰胺类药物低敏性 A 组链球菌。
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0148221. doi: 10.1128/AAC.01482-21. Epub 2021 Oct 4.
本文引用的文献
1
Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.大环内酯类耐药酿脓链球菌：流行情况和治疗策略。
Expert Rev Anti Infect Ther. 2015 May;13(5):615-28. doi: 10.1586/14787210.2015.1023292. Epub 2015 Mar 8.
2
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.皮肤和软组织感染诊断与管理实践指南：美国传染病学会 2014 年更新版。
Clin Infect Dis. 2014 Jul 15;59(2):e10-52. doi: 10.1093/cid/ciu444.
3
Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013.2012 年至 2013 年爱尔兰侵袭性 A 组链球菌病发病率上升。
Euro Surveill. 2013 Aug 15;18(33):20556. doi: 10.2807/1560-7917.es2013.18.33.20556.
4
Changes in Streptococcus pyogenes causing invasive disease in Portugal: evidence for superantigen gene loss and acquisition.葡萄牙引起侵袭性疾病的化脓性链球菌的变化：超抗原基因缺失和获得的证据。
Int J Med Microbiol. 2013 Dec;303(8):505-13. doi: 10.1016/j.ijmm.2013.07.004. Epub 2013 Jul 18.
5
Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?化脓链球菌对甲氧苄啶-磺胺甲恶唑是耐药还是敏感？
J Clin Microbiol. 2012 Dec;50(12):4067-72. doi: 10.1128/JCM.02195-12. Epub 2012 Oct 10.
6
Invasive Group A streptococcal disease in Ireland, 2004 to 2010.爱尔兰 2004 年至 2010 年侵袭性 A 组链球菌病。
Euro Surveill. 2011 Oct 13;16(41):19988.
7
Invasive group A streptococcal infections in adults, France (2006-2010).成人侵袭性 A 组链球菌感染，法国（2006-2010 年）。
Clin Microbiol Infect. 2012 Jul;18(7):702-10. doi: 10.1111/j.1469-0691.2011.03624.x. Epub 2011 Aug 29.
8
Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates.1998 年至 2009 年期间引起西班牙侵袭性疾病的酿脓链球菌分离株的流行病学和分子分析：与非侵袭性分离株的比较。
Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1295-302. doi: 10.1007/s10096-011-1226-x. Epub 2011 Apr 15.
9
mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.mef(A) 是德国肺炎链球菌和化脓性链球菌中主要的大环内酯类耐药决定因素。
Int J Antimicrob Agents. 2011 May;37(5):425-31. doi: 10.1016/j.ijantimicag.2011.01.019. Epub 2011 Mar 21.
Zotero 插件